Physician
Billings Clinic
Billings Clinic was paid $53.85M by Medicaid between Jan 2018 and Dec 2024, across 327 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 24% of everything it billed.
33Billing provider infoBILLINGS CLINIC
BILLINGS, MT 59101
BILLINGS, MT 59101
33aNPI1376598714assigned 05/24/2006
33bProvider typeAllergy & Immunology Physician
28Total paid$53.85M
24GClaims940,198
24DCodes billed327
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 156,278 | $7.51M | |
| 2019 | 139,515 | $7.41M | |
| 2020 | 110,522 | $5.90M | |
| 2021 | 135,249 | $8.00M | |
| 2022 | 139,723 | $9.02M | |
| 2023 | 151,591 | $9.11M | |
| 2024incomplete | 107,320 | $6.91M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 155,531 | 148,216 | $12.93M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 23% | 113,642 | 107,021 | $12.49M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 4.7% | 14,984 | 14,189 | $2.51M |
| 90792 | Psychiatric diagnostic evaluation with medical services | 3.1% | 10,779 | 10,255 | $1.66M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.0% | 32,946 | 32,305 | $1.61M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.3% | 10,512 | 10,315 | $1.26M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.2% | 10,601 | 9,895 | $1.16M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 2.0% | 16,309 | 7,688 | $1.08M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 1.8% | 8,780 | 3,729 | $960K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.7% | 15,809 | 14,147 | $918K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.5% | 6,861 | 6,553 | $820K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1.4% | 3,894 | 1,547 | $764K |
315 more codes
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.3% | 7,453 | $689K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.0% | 3,360 | $550K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 4,382 | $529K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 4,404 | $500K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 3,193 | $448K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 4,055 | $441K |
| 99285 | Emergency room visit (most serious) | <1% | 2,156 | $407K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 3,068 | $401K |
| 99284 | Emergency room visit (serious) | <1% | 2,952 | $385K |
| 36415 | Collection of venous blood by venipuncture | <1% | 84,559 | $332K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 2,134 | $324K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 4,137 | $318K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 7,698 | $318K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 2,550 | $310K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 2,511 | $272K |
| 99205 | Prolong outpt/office vis | <1% | 1,087 | $249K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 395 | $248K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 34,061 | $248K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 3,485 | $240K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 3,553 | $225K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 1,963 | $222K |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 1,704 | $209K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 9,704 | $206K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,541 | $205K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 2,809 | $201K |
| 92060 | <1% | 3,042 | $199K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 20,644 | $180K |
| 94060 | <1% | 3,126 | $170K | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 837 | $167K |
| 90837 | Psychotherapy session, about an hour | <1% | 2,258 | $165K |
| 99283 | Emergency room visit (moderate) | <1% | 2,151 | $165K |
| 71045 | Radiologic examination, chest; single view | <1% | 19,731 | $163K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 4,851 | $154K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 2,622 | $153K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 745 | $147K |
| 99217 | <1% | 2,058 | $144K | |
| 92015 | Determination of refractive state | <1% | 7,736 | $140K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,351 | $139K |
| 99223 | Prolong inpt eval add15 m | <1% | 747 | $139K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 2,240 | $124K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 1,323 | $120K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 7,439 | $118K |
| 93000 | <1% | 6,648 | $117K | |
| 80053 | Comprehensive metabolic panel | <1% | 10,308 | $114K |
| 90670 | <1% | 6,094 | $106K | |
| 76830 | Ultrasound, transvaginal | <1% | 956 | $102K |
| 81025 | <1% | 13,411 | $99K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 4,592 | $97K |
| 96131 | <1% | 423 | $96K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 1,803 | $95K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 7,215 | $95K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 3,016 | $94K |
| 94010 | <1% | 2,706 | $88K | |
| 90461 | <1% | 15,892 | $84K | |
| 90686 | <1% | 16,936 | $79K | |
| 73630 | <1% | 2,758 | $77K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 494 | $74K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 6,937 | $74K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 954 | $70K |
| 92134 | <1% | 2,481 | $69K | |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 926 | $67K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,017 | $66K |
| 99460 | <1% | 655 | $65K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 10,420 | $63K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,645 | $61K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 612 | $61K |
| J0178 | Injection, aflibercept, 1 mg | <1% | 26 | $60K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 774 | $56K |
| 99310 | Prolong nursin fac eval 15m | <1% | 1,353 | $53K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,107 | $52K |
| 99479 | Subsequent intensive care, per day, very low birth weight infant | <1% | 433 | $51K |
| 73610 | <1% | 1,624 | $47K | |
| 90651 | <1% | 896 | $45K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 286 | $45K |
| 85027 | <1% | 7,614 | $44K | |
| 96130 | <1% | 413 | $44K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 614 | $42K |
| 95117 | <1% | 3,380 | $42K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 924 | $42K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,776 | $41K |
| 99480 | Subsequent intensive care, per day, low birth weight infant | <1% | 355 | $40K |
| 93320 | <1% | 837 | $40K | |
| 88307 | <1% | 434 | $40K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 308 | $40K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 506 | $38K |
| 11721 | <1% | 1,979 | $37K | |
| S0281 | Medical home program, comprehensive care coordination and planning, maintenance of plan | <1% | 8,976 | $37K |
| 92567 | <1% | 3,311 | $37K | |
| 95811 | <1% | 59 | $37K | |
| 96137 | <1% | 229 | $36K | |
| 76642 | <1% | 450 | $35K | |
| 80061 | Lipid panel | <1% | 3,487 | $35K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 411 | $31K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 352 | $31K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 447 | $31K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 329 | $30K |
| 87492 | <1% | 1,002 | $30K | |
| 97803 | <1% | 663 | $30K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 287 | $30K |
| 87592 | <1% | 996 | $29K | |
| 93325 | <1% | 1,343 | $28K | |
| 85610 | <1% | 7,114 | $26K | |
| 96139 | <1% | 171 | $24K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 298 | $24K |
| 90723 | <1% | 3,752 | $22K | |
| 51784 | <1% | 425 | $22K | |
| 72141 | <1% | 307 | $22K | |
| 97802 | <1% | 355 | $22K | |
| 76801 | <1% | 174 | $22K | |
| 80047 | <1% | 1,813 | $22K | |
| 73110 | <1% | 608 | $21K | |
| 92557 | <1% | 807 | $21K | |
| 73130 | <1% | 777 | $21K | |
| 99443 | <1% | 211 | $21K | |
| 99218 | <1% | 234 | $21K | |
| 99220 | <1% | 120 | $21K | |
| 94729 | <1% | 449 | $21K | |
| 90961 | <1% | 266 | $20K | |
| 87210 | <1% | 3,901 | $20K | |
| 90680 | <1% | 2,601 | $19K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 310 | $18K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 41 | $17K |
| 87400 | <1% | 1,091 | $17K | |
| 81003 | <1% | 8,754 | $17K | |
| 95886 | <1% | 179 | $16K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 331 | $16K |
| 83655 | <1% | 1,166 | $15K | |
| 73030 | <1% | 587 | $15K | |
| 96136 | <1% | 369 | $15K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 21 | $14K |
| 87081 | <1% | 1,846 | $14K | |
| 88342 | <1% | 396 | $14K | |
| 96101 | <1% | 41 | $13K | |
| 96133 | <1% | 45 | $13K | |
| 81001 | <1% | 4,780 | $13K | |
| 92250 | <1% | 353 | $13K | |
| 92587 | <1% | 807 | $13K | |
| 99462 | <1% | 267 | $12K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 142 | $12K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,934 | $12K |
| 88141 | <1% | 399 | $11K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 516 | $11K |
| 73562 | <1% | 384 | $11K | |
| 95812 | <1% | 41 | $10K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 766 | $10K |
| 95251 | <1% | 339 | $10K | |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 449 | $10K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 28 | $10K |
| 81002 | <1% | 3,257 | $10K | |
| 96127 | <1% | 1,027 | $10K | |
| 90633 | <1% | 2,015 | $9K | |
| 84439 | <1% | 1,230 | $9K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 28 | $9K |
| 81514 | <1% | 43 | $9K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 185 | $9K |
| 99221 | <1% | 114 | $8K | |
| 93296 | <1% | 299 | $8K | |
| 76857 | <1% | 202 | $8K | |
| 85060 | <1% | 418 | $8K | |
| 17110 | <1% | 69 | $8K | |
| G0008 | Administration of influenza virus vaccine | <1% | 378 | $8K |
| 90734 | <1% | 256 | $8K | |
| 85018 | <1% | 3,306 | $7K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 40 | $7K |
| 82728 | <1% | 609 | $7K | |
| 71250 | <1% | 144 | $7K | |
| 90647 | <1% | 3,238 | $7K | |
| 73564 | <1% | 188 | $7K | |
| 93295 | <1% | 236 | $7K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 159 | $7K |
| 0002A | <1% | 270 | $6K | |
| 88304 | <1% | 460 | $6K | |
| 95806 | <1% | 123 | $6K | |
| 86703 | <1% | 457 | $6K | |
| 95813 | <1% | 12 | $6K | |
| 99219 | <1% | 48 | $6K | |
| 74018 | <1% | 328 | $5K | |
| 87070 | <1% | 686 | $5K | |
| 94726 | <1% | 116 | $5K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 41 | $5K |
| 99358 | Prolong nursin fac eval 15m | <1% | 41 | $5K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 38 | $4K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 12 | $4K |
| 99442 | <1% | 68 | $4K | |
| 92342 | <1% | 154 | $4K | |
| 87077 | <1% | 548 | $4K | |
| 96132 | <1% | 48 | $4K | |
| S0315 | Disease management program; initial assessment and initiation of the program | <1% | 522 | $4K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 96 | $4K |
| 90710 | <1% | 181 | $4K | |
| 92523 | <1% | 26 | $4K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 80 | $4K |
| 0071A | <1% | 100 | $4K | |
| 64615 | <1% | 24 | $4K | |
| 51798 | <1% | 615 | $3K | |
| 0001A | <1% | 211 | $3K | |
| 99349 | <1% | 123 | $3K | |
| 51741 | <1% | 342 | $3K | |
| 97165 | <1% | 147 | $3K | |
| 94664 | <1% | 162 | $3K | |
| 87510 | <1% | 186 | $3K | |
| 96138 | <1% | 139 | $3K | |
| 90677 | <1% | 210 | $3K | |
| 87660 | <1% | 185 | $3K | |
| 93971 | <1% | 63 | $3K | |
| 87480 | <1% | 186 | $3K | |
| 86140 | <1% | 656 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 403 | $3K |
| 90480 | <1% | 72 | $3K | |
| 91321 | <1% | 19 | $3K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 52 | $3K |
| 76818 | <1% | 21 | $3K | |
| 92588 | <1% | 100 | $3K | |
| 87186 | <1% | 308 | $2K | |
| 93294 | <1% | 152 | $2K | |
| 0072A | <1% | 61 | $2K | |
| 90962 | <1% | 35 | $2K | |
| 90707 | <1% | 139 | $2K | |
| D1206 | Topical application of fluoride varnish | <1% | 109 | $2K |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) | <1% | 30 | $2K |
| 59025 | Fetal non-stress test | <1% | 49 | $2K |
| 85651 | <1% | 526 | $2K | |
| 92083 | <1% | 39 | $2K | |
| 69210 | <1% | 44 | $2K | |
| 92579 | <1% | 82 | $2K | |
| 99354 | <1% | 12 | $2K | |
| 99201 | <1% | 49 | $2K | |
| 96121 | <1% | 15 | $2K | |
| A4627 | Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler | <1% | 437 | $2K |
| 83516 | <1% | 155 | $2K | |
| 76775 | <1% | 31 | $2K | |
| 82950 | <1% | 350 | $2K | |
| 93970 | <1% | 12 | $2K | |
| 73140 | <1% | 47 | $2K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 90 | $2K |
| 99336 | <1% | 47 | $2K | |
| 90656 | <1% | 575 | $2K | |
| 20610 | <1% | 30 | $1K | |
| 93976 | <1% | 14 | $1K | |
| 93308 | <1% | 15 | $1K | |
| 73100 | <1% | 38 | $1K | |
| 90715 | <1% | 123 | $1K | |
| 99406 | <1% | 96 | $1K | |
| 73502 | <1% | 41 | $1K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 23 | $1K |
| 82570 | <1% | 301 | $1K | |
| 77065 | Tomosynthesis, mammo | <1% | 12 | $1K |
| 70498 | <1% | 16 | $1K | |
| 82565 | <1% | 232 | $1K | |
| 11100 | <1% | 14 | $1K | |
| 0012A | <1% | 42 | $1K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 12 | $1K |
| 93016 | <1% | 67 | $1K | |
| 96161 | <1% | 382 | $1K | |
| 96116 | <1% | 15 | $1K | |
| 85652 | <1% | 620 | $1K | |
| 90696 | <1% | 137 | $1K | |
| 92611 | <1% | 13 | $1K | |
| 84481 | <1% | 65 | $1K | |
| 90716 | <1% | 25 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 88 | $1K |
| 11056 | <1% | 25 | $1K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 38 | $1K |
| 72100 | <1% | 41 | $981.49 | |
| 92550 | <1% | 61 | $980.90 | |
| 83540 | <1% | 230 | $959.14 | |
| 70496 | <1% | 14 | $894.59 | |
| 84436 | <1% | 133 | $891.49 | |
| 92552 | <1% | 30 | $827.49 | |
| 73080 | <1% | 28 | $792.63 | |
| 82784 | <1% | 88 | $789.60 | |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 21 | $754.82 |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | <1% | 161 | $749.90 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 37 | $725.28 |
| 73221 | <1% | 12 | $720.80 | |
| 0011A | <1% | 42 | $677.60 | |
| 95012 | <1% | 28 | $651.80 | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 13 | $626.35 |
| S0316 | Disease management program, follow-up/reassessment | <1% | 40 | $600.00 |
| 93321 | <1% | 24 | $595.14 | |
| 99499 | <1% | 68 | $594.00 | |
| 99359 | Prolong nursin fac eval 15m | <1% | 13 | $591.34 |
| 82962 | <1% | 225 | $520.70 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 40 | $509.76 |
| 72110 | <1% | 12 | $495.84 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 24 | $435.15 |
| 87420 | <1% | 30 | $406.72 | |
| G0316 | Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99223, 99233, and 99236 for hospital inpatient or observation care evaluation and management services). (do not report g0316 on the same date of service as other prolonged services for evaluation and management 99358, 99359, 99418, 99415, 99416). (do not report g0316 for any time unit less than 15 minutes) | <1% | 12 | $398.43 |
| 81015 | <1% | 239 | $362.21 | |
| 82043 | <1% | 65 | $359.50 | |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | <1% | 12 | $358.28 |
| 93018 | <1% | 27 | $356.16 | |
| 77072 | <1% | 14 | $346.75 | |
| 73590 | <1% | 12 | $338.20 | |
| 90700 | <1% | 87 | $334.49 | |
| V5264 | Ear mold/insert, not disposable, any type | <1% | 12 | $314.03 |
| 51702 | <1% | 12 | $231.04 | |
| 85007 | <1% | 89 | $226.08 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 29 | $224.62 |
| 86364 | <1% | 33 | $211.82 | |
| 87807 | <1% | 13 | $208.16 | |
| 87205 | <1% | 41 | $197.99 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 12 | $193.52 |
| 80069 | <1% | 15 | $152.66 | |
| V5299 | Hearing service, miscellaneous | <1% | 12 | $119.10 |
| 92593 | <1% | 13 | $109.36 | |
| 88300 | <1% | 13 | $84.68 | |
| 83735 | <1% | 20 | $84.58 | |
| 82607 | <1% | 17 | $79.18 | |
| 83690 | <1% | 15 | $75.79 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 13 | $75.66 |
| 83550 | <1% | 13 | $55.94 | |
| 84156 | <1% | 17 | $40.17 | |
| G0317 | Prolonged nursing facility evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99306, 99310 for nursing facility evaluation and management services). (do not report g0317 on the same date of service as other prolonged services for evaluation and management 99358, 99359, 99418). (do not report g0317 for any time unit less than 15 minutes) | <1% | 13 | $39.84 |
| 90685 | 0% | 115 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialQUINONES, KATHLEEN (CFO)
Parent organizationBILLINGS CLINIC
| Provider | Location | Paid |
|---|---|---|
| City Hospital, INC | Martinsburg, WV | $41.06M |
| Jefferson Memorial Hospital | Ranson, WV | $21.65M |
| Billings Clinic | Billings, MT | $15.71M |
| Billings Clinic | Billings, MT | $3.32M |
| Billings Clinic | Billings, MT | $2.99M |
| Billings Clinic | Billings, MT | $2.40M |
| Billings Clinic | Cody, WY | $110K |
| Billings Clinic | Billings, MT | $97K |
| Billings Clinic | Billings, MT | $20K |
| Billings Clinic | Livingston, MT | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.